Your browser doesn't support javascript.
loading
Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney and heart failure outcomes guided by HbA1c, albuminuria, and predicted risk of kidney failure.
Tye, Sok Cin; Jongs, Niels; Coca, Steven G; Sundström, Johan; Arnott, Clare; Neal, Bruce; Perkovic, Vlado; Mahaffey, Kenneth W; Vart, Priya; Heerspink, Hiddo J L.
Afiliação
  • Tye SC; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, PO Box 30001, 9700 RB, Groningen, The Netherlands.
  • Jongs N; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, PO Box 30001, 9700 RB, Groningen, The Netherlands.
  • Coca SG; Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Sundström J; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Arnott C; The George Institute for Global Health, UNSW Sydney, Sydney, NSW, Australia.
  • Neal B; The George Institute for Global Health, UNSW Sydney, Sydney, NSW, Australia.
  • Perkovic V; Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia.
  • Mahaffey KW; The George Institute for Global Health, UNSW Sydney, Sydney, NSW, Australia.
  • Vart P; The George Institute for Global Health, UNSW Sydney, Sydney, NSW, Australia.
  • Heerspink HJL; Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, CA, USA.
Cardiovasc Diabetol ; 21(1): 194, 2022 09 23.
Article em En | MEDLINE | ID: mdl-36151557
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Insuficiência Renal / Inibidores do Transportador 2 de Sódio-Glicose / Insuficiência Cardíaca Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cardiovasc Diabetol Assunto da revista: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Insuficiência Renal / Inibidores do Transportador 2 de Sódio-Glicose / Insuficiência Cardíaca Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cardiovasc Diabetol Assunto da revista: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda